When miR-222-3p was overexpressed in six cell lines, it was found that miR-222-3p targets on AKT phosphorylation protein regulator G protein alpha inhibiting activity polypeptide 2 (GNAI2), which inhibited AKT phosphorylation to reduce the proliferation of ovarian cancer cells [91]. The gene discussed is AKT1; the disease is ovarian cancer.